Massive X-ray screening reveals two allosteric drug binding sites of SARS-CoV-2 main protease

Summary
The coronavirus disease (COVID-19) caused by SARS-CoV-2 is creating tremendous health problems and economical challenges for mankind. To date, no effective drug is available to directly treat the disease and prevent virus spreading. In a search for a drug against COVID-19, we have performed a massive X-ray crystallographic screen of repurposing drug libraries1 containing 5953 individual compounds against the SARS-CoV-2 main protease (Mpro), which is a potent drug target as it is essential for the virus replication2. In contrast to commonly applied X-ray fragment screening experiments with molecules of low complexity, our screen tested already approved drugs and drugs in clinical trials. From the three-dimensional protein structures, we identified 37 compounds binding to Mpro. In subsequent cell-based viral reduction assays, one peptidomimetic and five non-peptidic compounds showed antiviral activity at non-toxic concentrations. Interestingly, two compounds bind outside the active site to the native dimer interface in close proximity to the S1 binding pocket. Another compound binds in a cleft between the catalytic and dimerization domain of Mpro. Neither binding site is related to the enzymatic active site and both represent attractive targets for drug development against SARS-CoV-2. This X-ray screening approach thus has the potential to help deliver an approved drug on an accelerated time-scale for this and future pandemics3.
Competing Interest Statement
The authors have declared no competing interest.
Subject Area
- Biochemistry (7796)
- Bioengineering (5675)
- Bioinformatics (21284)
- Biophysics (10578)
- Cancer Biology (8174)
- Cell Biology (11945)
- Clinical Trials (138)
- Developmental Biology (6763)
- Ecology (10401)
- Epidemiology (2065)
- Evolutionary Biology (13866)
- Genetics (9708)
- Genomics (13073)
- Immunology (8146)
- Microbiology (20014)
- Molecular Biology (7853)
- Neuroscience (43056)
- Paleontology (319)
- Pathology (1279)
- Pharmacology and Toxicology (2258)
- Physiology (3351)
- Plant Biology (7232)
- Synthetic Biology (2006)
- Systems Biology (5538)
- Zoology (1128)